The incidence of vascular adverse events and usefulness of novel risk assessment tool in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors
Our results clearly demonstrate that the Hisayama score can be used to evaluate VAE risk in high-risk patients. Selecting appropriate TKIs based on each patient risk, smoking cessation, and blood pressure control may contribute to selecting appropriate TKIs and managing VAE risk.
Authors
- Michihide Tokuhira (ORCID: https://orcid.org/0000-0003-3780-5331)
- Takayuki Tabayashi
- Toru Mitsumori
- Tatsuya Kawaguchi (ORCID: https://orcid.org/0000-0001-7727-3195)
- Miki Ando (ORCID: https://orcid.org/0000-0001-8871-1330)
- Yuta Kimura (ORCID: https://orcid.org/0000-0002-3525-1366)
- Hitomi Nakayama (ORCID: https://orcid.org/0000-0002-6474-1209)
- Eisaku Iwanaga (ORCID: https://orcid.org/0000-0001-5177-0070)
- Tomoiku Takaku (ORCID: https://orcid.org/0000-0002-6493-6225)
- Tomonori Nakazato (ORCID: https://orcid.org/0000-0003-3579-4018)
- Noriyoshi Iriyama (ORCID: https://orcid.org/0000-0001-9176-1988)
- Naoki Watanabe (ORCID: https://orcid.org/0000-0001-6377-0174)
- Hiroyuki Fujita (ORCID: https://orcid.org/0000-0001-8744-8411)
- Eriko Sato (ORCID: https://orcid.org/0000-0003-4159-2834)
- Maho Ishikawa (ORCID: https://orcid.org/0000-0003-0965-9007)
- Katsuhiro Miura
Institutions
- Nihon University (JP)
- Kumamoto Health Science University (JP)
- Juntendo University (JP)
- Saitama Medical University Hospital (JP)
- Kumamoto University Hospital (JP)
- Yokohama Municipal Citizen's Hospital (JP)
- Juntendo University Urayasu Hospital (JP)
- Social Insurance Saitama Chuo Hospital (JP)
- Saiseikai Ibaraki Hospital (JP)
- Juntendo University Nerima Hospital (JP)
- Saitama Medical University (JP)
Publication Details
- Journal
- Cardio-Oncology
- Published
- 2025-07-19
- DOI
- https://doi.org/10.1186/s40959-025-00366-x
- Primary Topic
- Chronic Myeloid Leukemia Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00